SOPHiA GENETICS (SOPH) Notes Payables (2020)

SOPHiA GENETICS's (SOPH) quarterly Notes Payables came in at $2.9 million in Q4 2020.

SOPHiA GENETICS (SOPH) Notes Payables (2020) Analysis & Trends

SOPHiA GENETICS has disclosed Notes Payables across 1 years of filings, most recently posting $2.9 million for Q4 2020.

  • Notes Payables for Q4 2020 came in at $2.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $2.9 million (changed N/A YoY), and the FY2020 annual result was $2.9 million, changed N/A from the prior year.
  • Notes Payables came in at $2.9 million for Q4 2020 at SOPHiA GENETICS.
  • In the past five years, Notes Payables ranged from a high of $2.9 million in Q4 2020 to a low of $2.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn
10 SOPHiA GENETICS 26.19 Mn -44.10 Mn 14.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 2.87 Mn